Get the Stockscreener App
1.52
2.70%
0.04
Metagenomi Inc stock is traded at $1.52, with a volume of 330.29K.
It is up +2.70% in the last 24 hours and down -19.15% over the past month.
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
See More
Previous Close:
$1.48
Open:
$1.5
24h Volume:
330.29K
Relative Volume:
0.44
Market Cap:
$56.82M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+10.14%
1M Performance:
-19.15%
6M Performance:
-23.62%
1Y Performance:
-81.58%
1-Day Range:
$1.46
$1.5374
1-Week Range:
$1.3606
$1.60
52-Week Range:
$1.23
$8.42
Metagenomi Inc Stock (MGX) Company Profile
Name
Metagenomi Inc
Sector
Industry
Phone
(510) 871-4880
Address
5959 HORTON STREET, EMERYVILLE
Compare MGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGX
Metagenomi Inc
|
1.52 | 56.82M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Metagenomi Inc Stock (MGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-07-24 | Initiated | H.C. Wainwright | Buy |
| May-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-05-24 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-24 | Initiated | Chardan Capital Markets | Buy |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Mar-05-24 | Initiated | Jefferies | Buy |
| Mar-05-24 | Initiated | TD Cowen | Outperform |
| Mar-05-24 | Initiated | Wells Fargo | Overweight |
View All
Metagenomi Inc Stock (MGX) Latest News
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN
Corebridge Financial Inc. Grows Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California against Metagenomi, Inc. - marketscreener.com
Sei Investments Co. Acquires New Stake in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Metagenomi, Inc. (NASDAQ:MGX) Shares Sold by Prudential Financial Inc. - Defense World
ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Can you still get a good price for Metagenomi Inc (MGX) Shares at this point? - uspostnews.com
Levi & Korsinsky Reminds Shareholders of an Investigation into Metagenomi, Inc. (MGX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
ATTENTION Metagenomi, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi Lawsuit – MGX - ACCESS Newswire
Q1 Earnings Forecast for Metagenomi Issued By HC Wainwright - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm - marketscreener.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of November 25, 2024 in Metagenomi LawsuitMGX - ACCESS Newswire
HC Wainwright Lowers Metagenomi (NASDAQ:MGX) Price Target to $7.00 - Defense World
MGX stock plunges to 52-week low, hits $1.24 amid downturn - Investing.com Canada
MGX stock plunges to 52-week low, hits $1.24 amid downturn By Investing.com - Investing.com South Africa
Metagenomi stock target cut to $7 at H.C. Wainwright - Investing.com Australia
Metagenomi stock target cut to $7 at H.C. Wainwright By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Boosts Stock Holdings in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Bank of New York Mellon Corp Purchases New Position in Metagenomi, Inc. (NASDAQ:MGX) - Defense World
Investors who lost money on Metagenomi, Inc.(MGX) should contact Levi & Korsinsky about pending Class ActionMGX - ACCESS Newswire
Chardan Capital Estimates Metagenomi FY2025 Earnings - Defense World
Bullish: Analysts Just Made A Significant Upgrade To Their Metagenomi, Inc. (NASDAQ:MGX) Forecasts - Yahoo
Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) - openPR.com
MGX stock touches 52-week low at $1.61 amid sharp annual decline - Investing.com Australia
MGX stock touches 52-week low at $1.61 amid sharp annual decline By Investing.com - Investing.com South Africa
Critical Contrast: Metagenomi (NASDAQ:MGX) & Kodiak Sciences (NASDAQ:KOD) - Defense World
Investigation announced for Long Term Investors in shares - openPR.com
Metagenomi, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for Details- MGX - ACCESS Newswire
Metagenomi Inc (MGX) Reports $78.1 Million Net Loss and $52.3 Mi - GuruFocus.com
Metagenomi (NASDAQ:MGX) Price Target Cut to $20.00 by Analysts at Wells Fargo & Company - Defense World
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last We - Asianet Newsable
Metagenomi (MGX) Expected to Announce Earnings on Wednesday - Defense World
Chardan Adjusts Price Target on Metagenomi to $13 From $15, Keeps Buy Rating -March 18, 2025 at 06:52 am EDT - Marketscreener.com
Metagenomi Reports Business Updates and Full Year 2024 Financial Results - GlobeNewswire
Metagenomi files for mixed shelf offering of up to $250 mlnSEC filing -March 17, 2025 at 06:21 pm EDT - Marketscreener.com
Metagenomi, Inc. SEC 10-K Report - TradingView
Metagenomi Inc Stock (MGX) Financials Data
There is no financial data for Metagenomi Inc (MGX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metagenomi Inc Stock (MGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wapnick Pamela | Chief Financial Officer |
Mar 05 '25 |
Sale |
1.87 |
1,808 |
3,390 |
59,684 |
| Wapnick Pamela | Chief Financial Officer |
Dec 05 '24 |
Sale |
1.86 |
1,559 |
2,900 |
61,492 |
| Wapnick Pamela | Chief Financial Officer |
Sep 05 '24 |
Sale |
2.88 |
6,265 |
18,043 |
63,051 |
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):